Invention Application
- Patent Title: LIPID-BASED RNA FORMULATIONS SUITABLE FOR THERAPY
-
Application No.: US18689727Application Date: 2022-09-09
-
Publication No.: US20240408032A1Publication Date: 2024-12-12
- Inventor: Hossam HEFESHA , Heinrich HAAS , Ferdia BATES , Christian HOTZ , Katalin KARIKÓ
- Applicant: BioNTech SE
- Applicant Address: DE Mainz
- Assignee: BioNTech SE
- Current Assignee: BioNTech SE
- Current Assignee Address: DE Mainz
- Priority: WOPCT/EP2021/074976 20210910
- International Application: PCT/EP2022/075168 WO 20220909
- Main IPC: A61K9/51
- IPC: A61K9/51 ; A61K9/00 ; A61K38/19 ; A61K38/20 ; A61K38/21
Abstract:
The present disclosure relates to RNA particles comprising phospholipids with a phosphatidylserine head group for delivering RNA to target tissues after administration, in particular after parenteral, intratumoral, or peritumoral administration, and compositions comprising such RNA particles. The present disclosure also relates to methods for preparing RNA particles described herein.
Public/Granted literature
- US1942851A Ophthalmic mounting Public/Granted day:1934-01-09
Information query
